We herein report the case of a pediatric patient suffering from subarachnoid hemorrhage (SAH) due to a ruptured internal carotid artery (ICA) saccular aneurysm. Considering the unfavorable anatomy and irregular shape of the aneurysm, a flow diverter (FD) stent was positioned in addition to coils in an acute setting. Cangrelor (Kengreal, Chiesi, USA) IV bolus followed by maintenance IV infusion was administered in addition to ASA at the time of intervention. Transitioning from cangrelor to thienopyridine (clopidogrel) was done the day after the procedure without any ischemic or hemorrhagic complications. The patient was discharged symptom-free 24 days later. We discuss technical considerations focusing specifically on antiplatelet therapy management.
ChenRZhangSYouC, et al.Pediatric intracranial aneurysms: changes from previous studies. Childs Nerv Syst2018; 34: 1697–1704.
2.
SlatorNTalibiSSMundilN, et al.Paediatric intracranial aneurysms: a British institutional review. Childs Nerv Syst2019; 35: 1197–1205.
3.
LevyMLLevyDMMannaB. Pediatric cerebral aneurysm. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK537085/ (accessed 28 November 2023).
4.
XuRXieMEYangW, et al.Epidemiology and outcomes of pediatric intracranial aneurysms: comparison with an adult population in a 30-year, prospective database. J Neurosurg Pediatr2021; 28: 685–694.
5.
AlawiAEdgellRCElbabaaSK, et al.Treatment of cerebral aneurysms in children: analysis of the Kids' Inpatient Database. PED2014; 14: 23–30.
6.
StiefelMFHeuerGGBasilAK, et al.Endovascular and SURGICAL treatment of ruptured cerebral aneurysms in pediatric patients. Neurosurgery2008; 63: 859–866.
7.
CherianJSrinivasanVFroehlerMT, et al.Flow diversion for treatment of intracranial aneurysms in pediatric patients: multicenter case series. Neurosurgery (Baltim)2020; 87: 53–62.
8.
Santos-FrancoJACruz-ArgüellesCAAgustin-AguilarF, et al.Intracranial aneurysms in pediatric population treated with flow diverters: a single-center experience. Surg Neurol Int2022; 13: 522.
9.
ShlobinNARazEShapiroM, et al.Pipeline embolization of cerebral aneurysms in pediatric patients: combined systematic review of patient-level data and multicenter retrospective review. J Neurosurg Pediatr2021; 27: 668–676.
MonaglePChanAKCGoldenbergNA, et al.Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest2012; 141: e737S–e801S.
12.
QamarABhattDL. Current status of data on cangrelor. Pharmacol Ther2016; 159: 102–109.
13.
AngiolilloDJBhattDLStegPG, et al.Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials. J Thromb Thrombolysis2015; 40: 317–322.
14.
CortezGMMonteiroASourourN, et al.The use of cangrelor in neurovascular interventions: a multicenter experience. Neuroradiology2021; 63: 925–934.
15.
AbsiMSainathanSBeasleyG, et al.Use of a novel antiplatelet agent cangrelor in an infant supported with a ventricular assist device. Artif Organs2020; 44: 532–533.
16.
FahnhorstSEBeasleyGGoldbergJF, et al.Novel use of cangrelor in pediatrics: a pilot cohort study demonstrating use in ventricular assist devices. Artif Organs2021; 45: 38–45.
17.
RussoRBoghiAGiorgianniA, et al.Silk Vista Baby flow diverter stent for ruptured intracranial aneurysms: a retrospective observational study. Neuroradiology2022; 64: 2031–2037.
18.
Ten BrinckMFMJägerMDe VriesJ, et al.Flow diversion treatment for acutely ruptured aneurysms. J Neurointerventional Surg2020; 12: 283–288.
19.
Aguilar-SalinasPAgnolettoGJBrasilienseLBC, et al.Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study. J Neurointerventional Surg2019; 11: 347–351.
20.
RolliniFFranchiFAngiolilloDJ. Drug-drug interactions when switching between intravenous and oral P2Y12 receptor inhibitors. JACC Cardiovasc Interv2017; 10: 130–132.
21.
BhattadVBGaddamSLassiterMA, et al.Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic events. Ann Transl Med2019; 7: 408.
22.
SteinhublSROhJJOestreichJH, et al.Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect. Thromb Res2008; 121: 527–534.
23.
MaltzLAGauvreauKConnorJA, et al.Clopidogrel in a pediatric population: prescribing practice and outcomes from a single center. Pediatr Cardiol2009; 30: 99–105.
